Kristina Gemzell-Danielsson ELECTED for FIGO executive board
Today, thursday 18 October Kristina was elected for FIGO executive board!
FIGO with its members from all parts of the world has an unique position in the efforts to ensure reproductive health to all and thus fulfilling the SDG goals of "leaving no one behind".
We all benefit from a strong international professional organization to support us in our clinical work and academic tasks but also in our communication with policy makers and society. There are many good examples how FIGO can encourage teamwork and the building of strong networks. One is the educational activity. Another is the implementation of science into clinical practice through evidence based guidelines and statements. We also need to contribute further to link together different professions and NGOs active within our field. Also, we will need to stay active to expand access to, and knowledge about, reproductive health and rights. For this we need to secure economic and human resources.
I strongly believe in FIGOs role in bringing together Health Care Professionals in Obstetrics and Gynecology from different countries and backgrounds for the common goal of bridging policy and academic research and education to the clinic to the benefit of our patients and society and to ensure reproductive health globally - globally in the sense of including all.
Professor, MD, PhD,
Chair Div. of Obstetrics and Gynecology
Dept. of Women´s and Children´s Health
Karolinska University Hospital
SE-171 76 Stockholm, Sweden
Tel.+46 8 517- 72128 (or -79539)
Fax. +46 8 517 74314
Kristina got the 2012 FIGO´s Award in Recognition of Women Obstetricians/Gynecologists
Kristina Gemzell Danielsson
Kristina Gemzell Danielsson is professor, and chair of Obstetrics and Gynecology, Department of Women’s and Children’s Health, Karolinska Institutet and senior consultant at the Karolinska University Hospital. She is head of the research group at the WHO collaborating centre for research and research training in Human Reproduction. She is Honorary Clinical Professor at Hong Kong University, and Honorary fellow FSRH, RCOG, UK. She is a member of the International Committee for contraceptive research (ICCR), Population Council/Rockefeller University, chair of the Swedish reference group on Family planning (FARG), Past president of the European Society for Contraception and Reproductive Health, and past president and current vice treasurer, FIAPAC, member of the scientific and technical advisory group of the special programme for Human Reproduction and Reproductive Health Research (STAG) WHO, Geneva and the international medical advisory panel (IMAP) IPPF. She is also a member of the Nobel Assembly, Karolinska Institutet. Her research is translational (experimental and clinical trials “from bench-to bed-to the hands of women”) with focus on endometrial function, embryo implantation, comprehensive abortion care, emergency contraception and development of new contraceptive technology with a worldwide network of collaborating investigators. She is the author of around 300 scientific publications. She initiated and participated in the development of the FIGO misoprostol guidelines, and was a member of the FIGO working group on prevention of unsafe abortion.